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ABSTRACT
EFFECTS OF GLUCOCORTICOIDS UPON PRO-INFLAMMATORY RESPONSES TO
ACUTE SLEEP FRAGMENTATION
Sleep loss is a common problem in humans who suffer from obstructive sleep apnea.
Sleep aids in the regulation of immune responses, some of which induce inflammatory
responses. Cytokines regulate the inflammatory process and are released in response to sleep
fragmentation (SF) in mice. Glucocorticoids are hormones that are released from the adrenal
cortices during a stress response and are considered to be anti-inflammatory and
immunosuppressive at high doses but may stimulate immune function on an acute level. The first
hypothesis tested was that normal physiological expression of glucocorticoids (Sham) will
display increased IL-1β and TNFα expression levels, while high concentrations of
glucocorticoids (Sham + CORT) will reduce inflammatory responses compared to ADX mice. It
was also hypothesized that mice subjected to acute SF (ASF) will display elevated levels of IL1β and TNFα compared to control mice (CON). Lastly, female mice will also show an increased
response in pro-inflammatory cytokines compared to males. To examine this possibility, male
and female C57BL6/J mice were subjected to adrenalectomy (ADX), ADX + corticosterone
(CORT; the major stress hormone in mice), Sham, or Sham + CORT and then exposed to either
acute (24 h) SF or no SF. The results from this study shed light on some of the impacts of sleep
loss on increasing pro-inflammatory cytokines, however many of these effects were mitigated by
corticosterone. Generally, corticosterone enhanced inflammatory responses on an at normal
physiological levels, but at high doses these inflammatory phenotypes were diminished. This
study also showed differences in responses by males and females, with females generally having
increased expression of IL-1β and TNFα. These findings will aid scientists and doctors to
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hopefully gain a better understanding of the effects of sleep loss and how glucocorticoids
mediate these responses in a sex- and tissue-dependent manner. Development of treatments
targeting responses detrimental to human health may be able to provide a better of quality of life
for individuals that experience sleep loss.

Keywords: glucocorticoids, sleep loss, sleep fragmentation, inflammatory responses, cytokines
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Introduction
Sleep is a vital process for humans and other animals to recuperate from daily energetic
demands, and any disruption or irregularity in sleep can induce cognitive, inflammatory,
immunological, and metabolic impairments. These deficiencies have large impacts on human
health outcomes (Faraut et al., 2012; Mullington et al., 2009; Ramlackhansingh et al., 2011). As
an example, sleep loss is directly correlated with an increase in cardiovascular morbidity, or
heart disease (Ferrie et al, 2007; Meier-Ewert et al., 2001). Recent work has suggested a new role
for sleep in mice, whereby the quantity of cerebrospinal fluid increases during sleep to facilitate
metabolic clearance of waste products in the brain; specifically, sleep loss reduces the clearance
of metabolic waste, such as beta-amyloid protein (Xie et al., 2013). The immune system, in turn,
responds to the build-up in waste products, leading to inflammatory responses that potentially
develop into chronic disease. As sleep loss becomes more widespread in society, we need to
better understand the implications of sleep on public health.
The increased prevalence of obesity in the U.S.A and other developed countries has
drastically increased obstructive sleep apnea (OSA) diagnoses (Meurling et al., 2019; Paxinos
and Franklin, 2012). Distinguishing factors of OSA include the recurrence of the airway
collapsing during sleep, disrupted sleep continuity – otherwise known as sleep fragmentation
(SF), and intermittent hypoxia. When someone suffers from chronic OSA, there is an increased
risk for cardiovascular and metabolic diseases which reduces quality of life (Gottlieb and
Punjabi, 2020). One method that doctors have relied upon to treat OSA is continuous positive
airway pressure (CPAP) therapy. This form of therapy helps mediate clinical symptoms, but only
if the individual adheres to the therapy and has access to healthcare. Untreated OSA can lead to a
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two- to three-fold risk of myocardial infarction (MI), along with resistant hypertension and
insulin resistance (Jullian-Desaves et al., 2015; Hla et al., 2015).
Empirical evidence and epidemiological studies have shown an association between sleep
loss and inflammatory responses in the brain and peripheral organs (Frank et al., 2010; Wisor et
al., 2011), although the exact mechanisms that underlie these associations are unclear. The
presence of this pro-inflammatory phenotype may provide a connection between adverse health
effects and disrupted sleep. An increase in proinflammatory cytokines in circulation, such as
interleukin-1β (IL-1β), IL-6 and tumor necrosis factor (TNF)-α, have been linked to poor sleep.
These cytokines attract and upregulate mediators of the inflammatory process, which in turn
stimulate the liver to express acute phase proteins (e.g., C-reactive protein (CRP)). In contrast to
pro-inflammatory cytokines, C-reactive protein does not exhibit diurnal variation (Meier-Ewert
et al., 2001), and increased levels have been associated with cardiovascular disease in individuals
at risk (Mullington et al., 2009; Nagai et al., 2010).
The physiological stress response can be activated by sleep fragmentation, restriction, or
deprivation, and involves the sympathetic nervous system (SNS) and the hypothalamic-pituitaryadrenal (HPA) axis (Meerlo et al., 2008). The adrenal cortex is stimulated by the HPA axis to
release glucocorticoids (corticosterone in mice and cortisol in humans). Glucocorticoids are
hormones that are known to mobilize energy stores, but they also regulate the immune system.
There is a long-standing dogma that glucocorticoids are anti-inflammatory and
immunosuppressive. Despite this notion, glucocorticoids can prime pro-inflammatory responses
in the brain (Lannan et al., 2012; Munhoz et al., 2006). In other studies, evidence suggests that
chronic exposure and high concentrations of glucocorticoids suppresses immune function,
whereas normal physiological production will stimulate it (Dhabhar, 2002; Dhabhar and
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McEwen, 1999). Therefore, it is plausible that rapid and early increases in glucocorticoid
concentrations due to sleep loss mediate inflammation and regulate disease states.
Research in the Ashley lab previously evaluated the effects of SNS activation of
inflammatory responses due to sleep loss, and determined that chemical sympathectomy
(temporary deactivation of the peripheral SNS nerve terminals for more than 72 hours) reduced
the inflammatory responses in peripheral tissues (Mishra et al., 2020), suggesting that SNS
activation regulates inflammatory responses due to acute SF. Chemical sympathectomy also
decreases pro-inflammatory cytokine gene expression in the brain due to SF (Ashley et al.,
2022). A surprising discovery from these studies was that one week of recovery from chronic SF
resolved inflammation in peripheral tissues, but not in brain. Further examinations of the SNS
using alpha- and beta-receptor adrenergic blockade on inflammatory responses reduced
inflammation, validating the chemical sympathectomy findings (Wheeler et al., 2021). A
different study conducted by Ashley and colleagues examined the effects of vascular sheer forces
due to elevated blood pressure upon the pro-inflammatory phenotype. Without direct activation
of the SNS, Ensminger et al. (unpublished) altered blood pressure through the renin-angiotensin
system (RAS) and investigated inflammatory markers due to SF. The results revealed that
inflammation due to SF is largely independent of blood pressure elevations (Ella et al., 2018).
Despite studies reporting inflammation following sleep loss, few have attempted to
distinguish potential mechanisms and pathways regulating pro-inflammatory responses due to
sleep loss in animals. The proposed research will systematically test the possible pathways by
performing pharmacological techniques on live animals. For this study, one prediction is that
glucocorticoids alter the development and regulation of sleep fragmentation induced
inflammation during acute SF in selected peripheral tissues (liver, spleen, fat, and heart) and
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brain regions (prefrontal cortex (PFC), hypothalamus and hippocampus). The first hypothesis
tested was that normal physiological expression of glucocorticoids (Sham) will display increased
IL-1β and TNFα expression levels, while high concentrations of glucocorticoids (Sham +
CORT) will reduce inflammatory responses compared to ADX mice. It was also hypothesized
that mice subjected to acute SF (ASF) will display elevated levels of IL-1β and TNFα compared
to control mice (CON). Lastly, female mice will display increased expression of IL-1β and TNFα
compared to male mice of respective treatment groups (Irwin, Carrillo, and Olmstead, 2010).
The current study assessed whether glucocorticoids alter the regulation and development of proinflammatory responses due to SF, which is commonly observed in patients diagnosed with
severe OSA. Glucocorticoids are released to aid in stress responses, in which SF has been shown
to activate the HPA axis suggesting a role for glucocorticoids mediating these responses. Along
with addressing how glucocorticoids may affect pro-inflammatory responses, this research will
also investigate whether sex differences are observed during the pro-inflammatory responses
following ASF. The results from this study may provide a mechanism for doctors and scientists
to develop therapies or interventions that may improve the quality of life for individuals
suffering from sleep disorders, more specifically severe OSA.
Materials and Methods
Animals
Male (M) and female (F) C57BL/6J mice (n = 160 (80 M: 80 F)) were housed in our
colony room (12:12-h light-dark cycle, lights on at 0800, 21℃ ± 1℃) at Western Kentucky
University. Mice were weaned at 21 days of age and housed in polypropylene cages comprised
of same-sex littermates with corncob bedding, and food (RM1800, Cincinnati Labs) and normal
drinking water ad libitum. This research project was conducted under approval by the
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Institutional Animal Care and Use Committee at Western Kentucky University (#19-14) and
procedures followed the National Institutes of Health’s “Guide for the Use and Care of
Laboratory Animals”.
Surgical Procedure
Mice (8-12 weeks of age) were subjected to bilateral adrenalectomies in which each
mouse was deeply anesthetized with 5% isoflurane in a closed container followed by clipping of
fur away from the surgical site on both sides of the mouse near the last rib and abdominal region.
Eye ointment was provided to prevent ocular desiccation. Each mouse was placed in lateral
recumbency, followed by a topical alcohol and betadine scrub to prevent infection at the surgical
site. Then, a 1-2 mm incision below the last rib was made on the skin and the muscular wall to
expose the adrenal gland. After the adrenal gland was removed by gentle teasing of the organ
away from the surrounding fat, the muscular wall was closed with absorbable suture. Following
closing of the muscular wall, wound clips were used to close the skin incisions. Each mouse
promptly received 0.5% bupivacaine at the surgical site to aid in pain relief. After one side was
completed, the other side was conducted in similar fashion as described above. After pain
medications were administered on the second side, mice received 1.0 mL i.p. injections of
lactated ringers to aid in fluid replacement. After receiving fluids, mice were placed in automated
sleep fragmentation chambers (Lafayette Instrument Company; Lafayette, IN; model 80390) on
heating pads until fully recovered, which was around 2 hours post-operatively. Buprenorphine
was given post-surgery as needed. The mice subjected to bilateral adrenalectomies accounted for
half of the research subjects of this experiment (40 M: 40 F), as shown in Table 1.
The remaining half of mice (40 M: 40 F) were subjected to a sham-adrenalectomy
surgery using same procedure described above except that the adrenal glands were kept intact.
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The drinking water varied between treatment groups where the sham-adrenalectomy (Sham)
mice received normal drinking water. The adrenalectomized (ADX) mice were provided with
0.9% saline drinking water (Sigma, St. Louis, MO). The final treatment groups, Sham +
Corticosterone (CORT) and ADX + CORT, were provided 0.9% saline drinking water with
corticosterone (25 µg/mL, Sigma). All groups received their respective drinking water following
the surgical procedures.
Experimental Protocol
After a full recovery from surgery (~1 week), sleep conditions were assigned to the sleep
chambers as either acute sleep fragmentation (ASF) or control (non-sleep fragmentation) for
each of the four different treatment groups for both sexes. Each cage contained no more than 5
same-sex mice with corncob bedding, food, and their respective water treatments ad libitum.
After acclimation to the sleep fragmentation chambers (4 days), mice were subjected to acute
sleep fragmentation (see below; 24 hours) with sample collection the following day at 0800.
Experiment: Acute Sleep Fragmentation (ASF)
After acclimation, eighty mice (n = 20 Sham (10 M : 10 F), n = 20 Sham + CORT (10 M
: 10 F), n = 20 ADX (10 M : 10 F) and n = 20 ADX + CORT (10 M : 10 F)) were subjected to
ASF in which the bar sweeps horizontally across the floor of the cage at an interval of 120
seconds, or 30 arousals per hour, for 24 hours (Figure 1). Mice are able to sleep between bar
sweeps, but not allowing for deep sleep or sufficient sleep. This rate mimics the degree of sleep
fragmentation observed in patients diagnosed with severe OSA (Ramesh 2009, Goyal, and
Johnson 2017). The sweeper is controlled by an electric motor in which settings can mimic sleep
fragmentation. Due to the lack of space between the bar and cage walls and floor, mice must step
over the bar while it is moving (bar moves across the cage in ca. 9 sec). Mice are known to sleep
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in between bar sweeps, thus experiencing SF and not complete sleep deprivation (Mishra et al.,
2020). Control mice (n = 80; n = 20 Sham (10 M : 10 F), n = 20 Sham + CORT (10 M : 10 F), n
= 20 ADX (10 M : 10 F) and n = 20 ADX + CORT (10 M : 10 F)) were not subjected to any bar
sweeps, but were still housed in the sleep fragmentation chamber.
Sample Collection
After acute sleep fragmentation, mice were rapidly anesthetized using isoflurane
induction (5%) and rapidly decapitated within 3 minutes for tissue gene expression studies and
blood collection for measurement of CORT levels. Trunk blood was collected from mice, kept
on ice for less than 20 minutes and spun at 3000×g for 30 min at 4°C. Serum was collected and
stored at -80°C for corticosterone ELISA analyses. For gene expression analyses, three brain
regions (prefrontal cortex (PFC), hypothalamus and hippocampus), liver, spleen, extra-oviductal
white adipose tissue (EOWAT) from females and epididymal white adipose tissue (EWAT) from
males, and heart were dissected from mice and stored in RNAlater solution (ThermoScientific) in
the freezer at -20°C. All tissue samples were stored at -20°C no more than 30 days before RNA
extraction.
Corticosterone ELISA
Serum levels of corticosterone (n = 6-10/group) were measured as per the manufacturer’s
protocols (Catalogue number- ADI-901-097, EnzoLife Sciences). Average intra- and inter-assay
coefficients of variation were 9.71% and 5.56% respectfully.
Measurement of cytokine gene expression
RNA was extracted from prefrontal cortices, hypothalami, hippocampi, liver, spleen,
EOWAT/EWAT and heart using RNeasy mini kits (Qiagen). The concentration levels of RNA
were measured using a NanoDrop 2000 Spectrophotometer (ThermoScientific). Total RNA was

7

reverse transcribed into complementary DNA (cDNA) using a high-capacity cDNA reverse
transcription kit (ThermoFisher Scientific, Cat number:4368813). The prepared cDNA was used
as template to determine relative cytokine gene expression levels using an ABI 7300 RT-PCR
system. Cytokine probes (IL-1β: Mm00434228_m1, TNFα: Mm00443258_m1 ; ThermoFisher
Scientific) labelled with fluorescent marker 5-FAM at the 5’ end and quencher MGB at the 3’end
were used for genes of interest along with 18S (primer-limited, VIC-labelled probe) as the
endogenous control according to the manufacturer’s instructions. Samples were run in duplicates
and the cycle threshold (Ct) obtained by fluorescence exceeding background levels was used to
calculate the relative expression levels of mRNA of genes of interest (IL-1β, TNF-α) relative to
the endogenous control (18S). The change in mRNA expression levels was determined by DDCt
analysis.
Statistical Analysis
Data are presented as mean (±SE) (v.1.3.1073, R Development Core Team, Boston, MA).
A three-way ANOVA assessed the effect of acute sleep fragmentation, the effect of the
corticosterone treatment, the effect of sex, and their interactions upon peripheral and brain
cytokine gene expression and CORT concentration. Tukey’s HSD test was used for post-hoc
analysis and conducted on sexes separately. Logarithmic transformation was used to satisfy the
requirement of homogeneity of variances. Results are presented as means ±1 SE, and p < 0.05
was considered statistically significant.
Results
Serum Corticosterone Concentration
ASF did not significantly increase serum corticosterone (Cort) concentration (F1,144 =
0.102 , p = 0.750 , Figure 2), but Sham + CORT and ADX + CORT groups (F3,144 = 33.491 , p <
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0.001 , Figure 2) and males (F1,144 = 75.695 , p < 0.001 , Figure 2) significantly increased serum
Cort levels while ADX mice (F3,144 = 33.491 , p < 0.001 , Figure 2) had reduced serum Cort
levels. An interaction effect between ASF and corticosterone treatment (F3,144 = 3.169 , p = 0.026
, Figure 2) showed increased Cort levels in Sham + CORT CON and ASF mice as well as ADX
+ CORT CON and ASF mice. Corticosterone treatment and sex also had an interaction effect
present (F3,144 = 15.191 , p < 0.001 , Figure 2) displaying elevated Cort levels in male CON and
ASF mice compared to females of respective corticosterone treatment groups. All other
interactions were non-significant. Post-hoc analyses (Tukey’s HSD , p < 0.05) revealed that
Sham + CORT and ADX + CORT mice had increased Cort levels compared to Sham and ADX
mice, however female ADX + CORT mice had reduced Cort levels. Sex differences were
observed with females generally having lower levels of Cort in circulation compared to males of
respective treatment groups. ASF and CON Sham + CORT and ADX + CORT groups had
significantly elevated Cort levels compared to ASF and CON Sham and ADX groups. Female
corticosterone treatment groups were had significantly lower levels of circulating Cort compared
to respective male corticosterone treatment groups.
Brain Responses
Prefrontal Cortex
ASF did not significantly increase IL-1β gene expression levels (F1,139 = 0.000 , p = 0.999
, Figure 3) whereas Sham mice (F3,139 = 14.146 , p < 0.001 , Figure 3) and males (F1,139 = 10.673
, p < 0.001 , Figure 3) had significantly increased IL-1β gene expression levels. An interaction
effect between sleep and corticosterone was present (F3,139 = 5.324 , p = 0.002 , Figure 3) in
which Sham CON and ASF mice had increased IL-1β gene expression levels. Other interactions
were non-significant. Tukey’s HSD (p < 0.05) showed that Sham + CORT and ADX + CORT
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mice had significantly reduced IL-1β mRNA expression levels compared with Sham and ADX
mice. Females also showed a significant decrease in IL-1β gene expression levels compared to
males of respective treatment groups. An interaction between ASF and CORT treatment showed
significantly reduced levels of IL-1β compared to respective CON and CORT treatment mice.
CON mice (F1,140 = 4.466 , p = 0.036 , Figure 4) had increased TNF-α gene expression
levels while ADX + CORT groups (F3,140 = 6.333 , p < 0.001 , Figure 4) had reduced TNF-α
gene expression levels. Sex (F1,140 = 0.885 , p = 0.348 , Figure 4) did not significantly affect
TNF-α gene expression levels. An interaction effect with corticosterone treatment and sex was
present (F3,140 = 3.166 , p = 0.026 , Figure 4) with male and female ADX + CORT mice showing
reduced TNF-α gene expression levels. All other interactions were non-significant. Post-hoc
analyses indicate male ADX + CORT ASF mice had significantly reduced TNF-α mRNA
expression levels compared to male Sham CON and ADX ASF mice (Tukey’s HSD , p < 0.05).
ASF mice typically had lower TNF-α gene expression levels compared to CON mice for both
males and females. No significant differences were observed among the female mice treatment
groups.
Hypothalamus
ASF had no significant effect on IL-1β gene expression levels (F1,141 = 2.451 , p = 0.120 ,
Figure 5). ADX + CORT groups (F3,141 = 11.244 , p < 0.001 , Figure 5) and males (F1,141 =
39.485 , p < 0.001 , Figure 5) displayed reduced IL-1β gene expression levels compared to?. A
secondary interaction effect between sleep and treatment was significant (F3,141 = 2.822 , p =
0.041 , Figure 5) in which ADX + CORT ASF mice had reduced IL-1β gene expression levels.
No other interactions had significant effects on IL-1β gene expression levels. Post-hoc analyses
showed specifically that male ADX + CORT ASF mice had decreased IL-1β gene expression

10

levels compared to male Sham + CORT ASF and CON and male ADX CON and ASF groups
(Tukey’s HSD, p < 0.05). All female groups were similar in IL-1β gene expression levels
regardless of sleep treatment or corticosterone treatment.
ASF (F1,140 = 0.542 , p = 0.463 , Figure 6) and sex (F1,140 = 1.417 , p = 0.236 , Figure 6)
were non-significant in affecting TNF-α gene expression levels, whereas ADX mice (F3,140 =
38.486 , p < 0.001 , Figure 6) had significantly decreased TNF-α gene expression levels.
Secondary interaction effects between ASF and corticosterone treatment were present (F3,140 =
35.775 , p < 0.001 , Figure 6) with ADX ASF and ADX + CORT CON mice displaying reduced
TNF-α mRNA expression levels; corticosterone treatment and sex also had a significant
interaction effect (F3,140 = 3.530 , p = 0.017 , Figure 6) with female and male ADX groups
showing reduced TNF-α gene expression levels. All other interactions had no significant effects
on TNF-α gene expression levels. Tukey’s HSD (p < 0.05) showed that male ADX ASF and
male ADX + CORT CON had significantly reduced levels of TNF-α mRNA expression
compared to all other male mice. Female ADX ASF and female ADX + CORT CON also had
significantly reduced levels of TNF-α mRNA expression compared to all other female mice.
Hippocampus
ASF (F1,141 = 9.997 , p = 0.002 , Figure 7) and Sham and Sham + CORT groups (F3,141 =
13.573 , p < 0.001 , Figure 7) had increased cytokine gene expression levels of IL-1β, whereas
sex (F1,141 = 0.408 , p = 0.524 , Figure 7) had no significant main effect on IL-1β gene expression
levels. There was a significant interaction between corticosterone treatment and sex (F3,141 =
4.663 , p = 0.004 , Figure 7) in which female Sham, female Sham + CORT, male Sham, male
Sham + CORT, and male ADX groups had increased IL-1β gene expression levels. Other
interactions were non-significant. Post-hoc analyses (Tukey’s HSD , p < 0,.05) showed no
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specific group differences among the male mice groups, however female ADX and ADX +
CORT CON groups had significantly reduced IL-1β gene expression levels compared to female
Sham CON and ASF treatment groups. Tukey’s HSD also revealed that Sham + CORT and
ADX + CORT groups for both males and females had reduced IL-1β gene expression levels
compared to Sham and ADX mice regardless of sleep treatment, however female ADX + CORT
ASF mice have increased mRNA expression levels of IL-1β.
Sham and Sham + CORT groups (F3,138 = 5.023 , p = 0.002 , Figure 8) and females (F1,138
= 4.677 , p = 0.032 , Figure 8) had significantly increased TNF-α gene expression levels,
whereas ASF (F1,138 = 0.101 , p = 0.752 , Figure 8) was not significant in affecting TNF-α gene
expression levels. No interaction effects were significant in affecting TNF-α gene expression
levels. Post-hoc analyses (Tukey’s HSD , p < 0.05) revealed significant differences in female
ADX + CORT CON mice compared to female Sham CON mice. Sham + CORT and ADX +
CORT mice, regardless of sex, had significant effects on reducing TNF-α gene expression levels
compared to Sham and ADX mice. All other groups were not significantly different from each
other.
Peripheral Tissue Responses
Liver
ASF (F1,138 = 2.431 , p = 0.121 , Figure 9) did not significantly affect IL-1β gene
expression levels, but ADX + CORT F3,138 = 19.227 , p < 0.001 , Figure 9) reduced L-1β gene
expression levels while females (F1,138 = 62.913 , p < 0.001 , Figure 9) had increased IL-1β gene
expression levels. An interaction effect between corticosterone treatment and sex was present
(F3,138 = 5.951 , p < 0.001 , Figure 9) where male ADX + CORT mice had reduced IL-1β gene
expression levels. No other interactions were significant. Tukey’s HSD (p < 0.05) identified that
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females generally had increased gene expression levels of IL-1β compared to males, however the
female mice did not significantly differ from each other. Male ADX + CORT CON had reduced
IL-1β gene expression levels compared to all other male treatment groups except for ADX +
CORT ASF. Male ADX + CORT ASF also differed significantly from male Sham CON and
male ADX CON groups.
ASF (F1,126 = 17.897 , p < 0.001 , Figure 10), Sham + CORT and ADX + CORT groups
(F3,126 = 17.894 , p < 0.001 , Figure 10), and males (F1,126 = 74.673 , p < 0.001 , Figure 10) had
significantly decreased expression levels of TNF-α. A secondary interaction effect between
corticosterone treatment and sex was present (F3,126 = 6.931 , p < 0.001 , Figure 10) with male
Sham + CORT and male ADX + CORT mice displaying reduced TNF-α gene expression levels.
No other interactions were significant. Post-hoc analyses (Tukey’s HSD , p < 0.05) revealed that
female mice had increased TNF-α gene expression levels compared to male mice individually
and in respect to corticosterone treatment groups. Male ADX CON had increased TNF-α gene
expression levels compared to male Sham + CORT ASF and both male ADX + CORT sleep
treatment groups. Male Sham CON and male Sham + CORT CON also displayed increased
TNF-α gene expression levels compared to both male ADX + CORT sleep treatment groups.
Female Sham + CORT ASF displayed reduced TNF-α mRNA expression levels compared to
female Sham CON and female ADX CON groups.
Spleen
ASF (F1,130 = 10.137 , p = 0.002 , Figure 11), Sham and ADX groups (F3,130 = 11.557 , p
< 0.001 , Figure 11), and females (F1,130 = 12.918 , p < 0.001 , Figure 11) had increased IL-1β
gene expression levels. A secondary interaction between corticosterone treatment and sex was
present (F3,130 = 16.587 , p < 0.001 , Figure 11) with male Sham + CORT and male ADX +
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CORT displaying reduced IL-1β gene expression levels. No other interactions were significant.
After finding significant effects among all three variables, post-hoc analyses (Tukey’s HSD , p <
0.05) were conducted and identified both male ADX + CORT treatment groups with reduced IL1β gene expression levels compared to all other male treatment groups except for both male
Sham + CORT groups. Male Sham + CORT CON mice also displayed reduced IL-1β gene
expression levels compared to male Sham ASF and male ADX ASF mice. Along with these
findings, male mice supplemented with corticosterone ( + CORT) had reduced IL-1β gene
expression levels compared to both male Sham and both male ADX treatment groups. All female
treatment groups had similar IL-1β gene expression levels compared to each other.
ASF (F1,134 = 1.747 , p = 0.189 , Figure 12) was not a significant main effect for TNF-α
gene expression levels, but Sham + CORT groups had reduced TNF-α gene expression levels
(F3,134 = 17.406 , p < 0.001 , Figure 12) while females (F1,134 = 6.795 , p = 0.010 , Figure 12) had
significantly increased TNF-α gene expression levels. A secondary interaction effects between
ASF and corticosterone treatment was significant (F3,130 = 3.283 , p = 0.023 , Figure 12) with
ADX ASF mice displaying increased TNF-α gene expression levels while Sham + CORT CON
and Sham + CORT ASF had decreased TNF-α gene expression levels. A second interaction
effect between corticosterone treatment and sex was present (F3,130 = 19.375 , p < 0.001 , Figure
12) in which male Sham + CORT and male ADX + CORT mice had reduced TNF-α gene
expression levels. All other interaction effects were non-significant. Post-hoc analyses utilizing
Tukey’s HSD (p < 0.05) showed specifically that both male Sham + CORT groups had reduced
TNF-α mRNA expression levels compared to both male Sham and male ADX ASF treatment
groups. Male ADX CON mice and both male ADX + CORT treatment groups also had reduced
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TNF-α gene expression levels compared to male Sham CON and male ADX ASF mice. Female
mice did not differ significantly in TNF-α mRNA expression levels compared to each other.
Epididymal White Adipose Tissue (EWAT – M) / Extra-oviductal White Adipose Tissue (EOWAT
– F)
Main effects on IL-1β gene expression levels for Sham groups (F3,139 = 7.205 , p < 0.001
, Figure 13) and females (F1,139 = 28.091 , p < 0.001 , Figure 13) were significantly increased
whereas ASF (F1,139 = 2.078 , p = 0.152 , Figure 13) was not significant. An interaction effect
between corticosterone treatment and sex was present (F3,139 = 2.931 , p = 0.036 , Figure 13) in
which male Sham + CORT and male ADX + CORT groups had reduced IL-1β gene expression
levels. No other significant interactions occurred. A Tukey’s HSD test (p < 0.05) was conducted
after significant effects were found to influence IL-1β gene expression levels. Results obtained
showed that female mice did not significantly differ from other female mice. Female mice
generally had elevated IL-1β gene expression levels compared to male mice overall and between
respective treatment groups, except for male Sham ASF mice. Male Sham + CORT CON mice
displayed reduced IL-1β mRNA levels compared to both male Sham treatment groups. All other
male treatment groups did not have significant differences in IL-1β gene expression levels.
ASF (F1,134 = 0.0031 , p = 0.956 , Figure 14) did not significantly affect TNF-α gene
expression levels, whereas Sham + CORT mice had reduced TNF-α gene expression levels
(F3,134 = 13.155 , p < 0.001 , Figure 14) and females had increased TNF-α mRNA expression
levels (F1,134 = 58.853 , p < 0.001 , Figure 14). An interaction effect between corticosterone
treatment and sex was significant (F3,134 = 2.686 , p = 0.049 , Figure 14) with female ADX,
female ADX + CORT and female Sham groups displaying increased TNF-α gene expression
levels. All other interactions had no significant affect on TNF-α gene expression levels. Post-hoc
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analyses (Tukey’s HSD , p < 0.05) revealed that all male mice had similar TNF-α gene
expression levels in comparison to other male mice treatment groups. Female Sham + CORT
ASF mice had reduced TNF-α gene expression levels compared to female Sham CON and both
female ADX treatment groups. Female Sham + CORT CON mice also had reduced TNF-α
mRNA expression levels in comparison to both female ADX treatment groups. All other group
differences were non-significant for TNF-α gene expression levels.
Heart
ASF (F1,143 = 0.027 , p = 0.869 , Figure 15) and sex (F1,143 = 0.785 , p = 0.377 , Figure
15) did not significantly effect IL-1β gene expression levels, but Sham and ADX treatment
groups (F3,143 = 39.400 , p < 0.001 , Figure 15) had significantly increased IL-1β gene expression
levels. A secondary interaction effect between sleep and corticosterone treatment was present
(F3,143 = 3.654 , p = 0.014 , Figure 15) with Sham CON, Sham ASF, ADX CON, and ADX ASF
all having increased IL-1β gene expression levels. Another interaction effect between
corticosterone treatment and sex was identified (F3,143 = 8.504 , p < 0.001 , Figure 15) in which
male Sham, male ADX and female ADX mice had increased IL-1β gene expression levels. Other
interactions were non-significant. Tukey’s HSD (p < 0.05) post-hoc analyses identified reduced
IL-1β gene expression levels, in general, for corticosterone supplemented ( + CORT) treatment
groups. Both male Sham + CORT treatment groups and male ADX + CORT ASF mice had
reduced IL-1β gene expression levels in relation to both male Sham treatment groups and both
male ADX treatment groups. Along with the significant findings for the male treatment groups,
both female ADX treatment groups had elevated IL-1β mRNA expression levels compared to
female ADX + CORT ASF mice. All other female groups were not significantly different from
each other in IL-1β gene expression levels.
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Sham + CORT treatment groups (F3,143 = 13.510 , p < 0.001 , Figure 16) had significantly
reduced TNF-α gene expression levels, whereas ASF (F1,143 = 0.369 , p = 0.545 , Figure 16) and
sex (F1,143 = 0.476 , p = 0.492 , Figure 16) did not significantly affect TNF-α gene expression
levels. A secondary interaction effect between corticosterone treatment and sex was significant
(F3,143 = 9.549 , p < 0.001 , Figure 16) in which male Sham + CORT mice had reduced TNF-α
gene expression levels. All other interaction effects did not significantly affect TNF-α gene
expression levels. Post-hoc analyses (Tukey’s HSD , p < 0.05) revealed specifically that male
Sham CON mice had increased TNF-α gene expression levels compared to both male Sham +
CORT treatment groups. All other male treatment groups had similar TNF-α gene expression
levels regarding each other. Female mice did not differ significantly in TNF-α mRNA expression
levels compared to each other. Corticosterone supplementation ( + CORT) and sex combined had
significantly reduced TNF-α gene expression levels in comparison to both Sham and ADX
treatment groups in combination with sex.
Discussion
The results obtained from this study show variable inflammatory responses to acute sleep
fragmentation (ASF), but these effects observed were tissue-specific. Some of the results
obtained are consistent to previous research in which acute sleep fragmentation may stimulate
pro-inflammatory responses (Dumaine and Ashley 2015, Mishra et al. 2020). As shown in Table
2, increased levels of IL-1β were observed in the hippocampus and spleen, whereas the
prefrontal cortex (PFC) and liver displayed reduced TNF-α gene expression levels (Table 3).
This varied response may be in part due to glucocorticoids, like corticosterone, regulating proinflammatory cytokine production. In relation to corticosterone treatment, the results indicate a
potential mechanism in which glucocorticoids may mediate these inflammatory responses due to
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ASF, but the effects varied by tissues. These findings are consistent with previous research that
showed glucocorticoids may prime pro-inflammatory cytokines in the brain as seen with IL-1β in
the PFC and hippocampus or TNF-α in the hippocampus (Lannan et al., 2012; Munhoz et al.,
2006). Other research has shown that physiological levels of glucocorticoids may stimulate
inflammatory responses, while chronic exposure and high concentrations may diminish these
pro-inflammatory responses (Dhabhar, 2002; Dhabhar and McEwen, 1999). Many of the
findings from this study indicate that this may be true in which corticosterone production may
stimulate pro-inflammatory responses in different tissues on an acute level. In Table 3, high
concentrations of corticosterone (Sham + CORT) lead to a reduction in pro-inflammatory
cytokines in peripheral tissues but increased inflammatory responses in the hippocampus. Along
with these findings, this study also supports previous research that showed females display
increased pro-inflammatory cytokine production compared to males (Irwin, Carrillo, and
Olmstead, 2010). Together these findings show sex differences in varied pro-inflammatory
phenotypes due to ASF which may be largely mediated by glucocorticoids, such as
corticosterone.
Sleep fragmentation has been associated with increased pro-inflammatory cytokines,
however the findings from this study largely contradict those findings about sleep loss (Faraut et
al., 2012; Mullington et al., 2009; Ramlackhansingh et al., 2011). Most tissues were not affected
by ASF, as shown in Table 2 and Table 3, but this may be in part due to the interaction effect
between sex and SF observed for both IL-1β or TNF-α. Although SF may not have been a
significant main effect on pro-inflammatory cytokine expression, there is a significant interaction
effect between SF and corticosterone treatment. As Table 2 indicates, Sham CON and Sham ASF
mice displayed increased IL-1β expression levels in the prefrontal cortex and heart. This
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increased inflammatory response in the heart may play a role in the development of
cardiovascular disease, which previous research has shown sleep loss is directly correlated with
heart disease (Ferrie et al, 2007; Meier-Ewert et al., 2001). Along with these findings, ADX +
CORT ASF mice also displayed reduced IL-1β gene expression levels in the hypothalamus.
Together these findings suggest a potential role for glucocorticoids mediating inflammatory
responses due to sleep loss. The decreased expression levels observed in the hypothalamus may
be part of a feedback loop trying to restore homeostasis by reducing glucocorticoid production
which may lead to decreased inflammatory responses.
In contrast to IL-1β expression levels, TNF-α displayed reduced expression levels in the
hypothalamus for ADX + CORT CON mice which again may be playing a role in regulating
inflammatory responses through the hypothalamus, as this is a major regulatory center for
signaling pathways involving the HPA axis to mediate stress responses such as sleep
fragmentation (Meerlo et al., 2008). Lastly, ADX ASF mice displayed increased TNF-α mRNA
expression levels, while Sham + CORT CON and Sham + CORT ASF mice had reduced TNF-α
expression levels. This finding again supports the potential role of glucocorticoids regulating
inflammatory responses, as empirical studies have shown that high concentrations of
glucocorticoids may diminish inflammatory responses (Dhabhar, 2002; Dhabhar and McEwen,
1999).
Aside from sleep fragmentation, mice also varied among corticosterone treatments as we
were investigating the potential roles of glucocorticoids on inflammatory responses due to sleep
loss. Given the contradictory results on SF in relation to previous research, some of the findings
about glucocorticoids may vary in response as well. The expression levels of IL-1β were
increased for Sham mice in the prefrontal cortex, hippocampus, spleen, adipose tissue, and heart
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which suggests the potential role for normal production of glucocorticoids to stimulate
inflammatory responses (Dhabhar, 2002; Dhabhar and McEwen, 1999). Along with this potential
role of glucocorticoids increasing inflammatory responses on an acute level, these findings also
support research that glucocorticoids also stimulate inflammatory responses in the brain (Lannan
et al., 2012; Munhoz et al., 2006). However, these findings are only in relation to IL-1β, as the
results obtained for TNF-α show decreased expression levels in the prefrontal cortex of ADX +
CORT mice, but increased expression in the hippocampus of Sham mice. These varying results
need to be investigated further to assess the differences in how glucocorticoids may mediate proinflammatory cytokine production. As indicated in Table 3, TNF-α expression levels decreased
for Sham + CORT mice in the liver, spleen, adipose tissue, and heart again suggesting that high
concentrations of glucocorticoids may reduce inflammatory responses (Dhabhar, 2002; Dhabhar
and McEwen, 1999). Along with the main effect findings for corticosterone, significant
interaction effects were observed which indicate normal physiological production of
glucocorticoids due to sleep loss will enhance some of these pro-inflammatory responses. An
interaction effect between SF and corticosterone treatment shows that Sham CON and Sham
ASF mice have increased IL-1β expression levels in the prefrontal cortex and heart (Table 2)
relative to all other treatment groups. The increased expression of pro-inflammatory cytokines in
the heart has been linked to increased heart disease in individuals suffering from chronic OSA
(Gottlieb and Punjabi, 2020). The increase in inflammatory cytokines can stimulate production
of other inflammatory mediators, such as C-reactive protein (CRP), which has been shown to
have increased concentration levels in individuals at risk for cardiovascular disease (Mullington
et al., 2009; Nagai et al., 2010). Sham + CORT CON and Sham + CORT ASF mice had reduced
TNF-α expression levels in the spleen (Table 3), which supports previous research that high
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concentrations of glucocorticoids will reduce inflammatory responses (Dhabhar, 2002; Dhabhar
and McEwen, 1999).
As the evidence shows, corticosterone treatment and SF have significant effects on
inflammatory responses, but corticosterone treatment and sex also had significant interaction
effects on these inflammatory responses as well. As expected, the female Sham, female Sham +
CORT, male Sham, and male Sham + CORT had increased IL-1β in the hippocampus (Table 2).
Male Sham mice also had increased IL-1β in the heart (Table 2). In contrast to these increased
responses due to varying corticosterone treatments, male ADX + CORT mice had decreased IL1β expression levels in the liver, spleen, and adipose tissue. The varying responses in
corticosterone treatment with sex should be investigated further to establish a better
understanding and role sex has on glucocorticoid production and regulation. As Table 3 shows,
male Sham + CORT mice also had reduced TNF-α mRNA levels in the liver, spleen, and heart.
The differences in increased IL-1β compared to decreased TNF-α should be further investigated
as these two pro-inflammatory cytokines may vary in responses to glucocorticoids, sleep loss or
sex. These findings do not fully support previous research that natural physiological production
of glucocorticoids will stimulate inflammatory response, while high concentrations or chronic
exposure will reduce these inflammatory responses as shown by (Dhabhar, 2002; Dhabhar and
McEwen, 1999).
This study supports previous research about sex differences observed in males and
females. The results summarized in Table 2 show that males generally have a decreased
expression level of IL-1β compared to females, except in the prefrontal cortex where males have
an increased expression of IL-1β. The hippocampus and heart had no significant differences
between the two sexes. Further investigation of TNF-α produced similar results in which males
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had lower expression levels compared to females, however the prefrontal cortex, hypothalamus
and heart did not significantly differ between the two sexes. These findings on the effects of sex
differences further support research showing that female mice generally have increased proinflammatory responses compared to males (Irwin, Carrillo, and Olmstead, 2010). This study
indicates there are clear differences in male and female responses due to sleep loss and vary in
response depending on tissue type. Although there were not significant interactions between SF
and sex for either pro-inflammatory cytokine assessed in this study, there was a significant
interaction effect between corticosterone treatment and sex. For IL-1β gene expression (Table 2),
female Sham, female Sham + CORT, male Sham, and male Sham + CORT had increased
expression levels compared to the other treatment groups in the hippocampus. Male sham mice
also showed increased IL-1β expression levels compared to other mice in heart. This finding,
along with increased IL-1β mRNA expression levels for male Sham + CORT mice for spleen,
adipose tissue, and heart further support that glucocorticoids on an acute level can enhance IL-1β
expression (Dhabhar, 2002; Dhabhar and McEwen, 1999). Male ADX + CORT mice also
showed reduced IL-1β expression levels in the liver, spleen, and adipose tissue which is
surprising given that male Sham mice showed increased inflammatory responses and the ADX +
CORT treatment should show similar levels. This may be due to the high levels of corticosterone
obtained in the drinking water, as these mice show pharmacological levels of corticosterone.
The expression levels of TNF-α have an opposite trend compared to IL-1β, in which male
Sham + CORT mice show reduced TNF-α mRNA expression in liver, spleen, and heart tissue
(Table 3). Male ADX + CORT showed a similar trend for TNF-α with reduced expression
occurring in the prefrontal cortex, liver, and spleen. Male and female ADX mice displayed
reduced TNF-α levels compared to other mice in the hypothalamus which again supports the idea
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that natural physiological production of glucocorticoids may enhance pro-inflammatory cytokine
production (Dhabhar, 2002). As I previously stated, one potential reason why the hypothalamus
may be showing reduced pro-inflammatory cytokine expression levels could be due to a potential
feedback mechanism associated with the HPA axis that becomes activated due to sleep
fragmentation (Meerlo et al., 2008). This hypothesis would need to be further tested to gain a
better understanding of the big picture on how sleep loss affects our immune systems
inflammatory responses. Along with this, future studies need to determine the specific roles that
glucocorticoids, such as corticosterone or cortisol, play in mediating these pro-inflammatory
responses in general and due to sleep loss.
The findings of sleep fragmentation on inflammatory responses in this study may differ
from previous research due to the rate of SF. It has been previously reported that mice exposed to
SF at a greater rate (60 bar sweeps/minute) exhibit more extensive inflammation across tissues
compared with the rate chosen for this study (Dumaine et al. 2015). Another potential source of
error could be the inclusion of both sexes in this study. Many studies in the past have conducted
research on male subjects with limited data on females and sleep loss. Along with limited female
data, very few previous studies have investigated combining both sexes which could lead to a
skewed understanding of how sleep loss may vary among the two different sexes. As sex
differences have been a limiting factor in previous research, this study aimed to gain a better
understanding about the effects of sleep loss between the two sexes.
Some potential sources of error for glucocorticoid treatment may have come from the
surgeries conducted on the mice. As shown in Figure 2, the corticosterone concentrations levels
between male Sham and male ADX mice is not significantly different from each other, and both
have similar levels of corticosterone. In contrast, the females have significantly reduced

23

corticosterone production in ADX mice compared to Sham mice which indicates that the
adrenalectomy surgeries for the males may not have been successful in abolishing corticosterone
production, thus influencing the results obtained in this study. Another potential source of error
could have been the amount of drinking water with corticosterone consumed. As Figure 2 shows,
female ADX + CORT mice have an elevated corticosterone concentration compared to female
ADX and female Sham mice, but these levels are not as significantly high as the male ADX +
CORT mice; however, as I previously stated, the male ADX + CORT mice may not have been
fully adrenalectomized, therefore resulting in similar concentration levels to male Sham + CORT
mice. Female mice may also have been drinking less water than the males which could also have
influenced the reduced female ADX + CORT corticosterone concentration levels compared to
male ADX + CORT mice. Given these two major sources of error for corticosterone treatment,
these results may be inaccurate and future studies should purchase adrenalectomized mice along
with finding better ways to supplement the hormone to ensure each mouse is receiving the proper
corticosterone treatment.
In conclusion, this study provides mixed support for sleep fragmentation promoting
inflammatory responses, as the effects of sleep fragmentation on these responses were not as
pronounced as other studies (Dumaine and Ashley, 2015; Mishra et al. 2020 et al.). Studies have
reported the significant effects of different types of sleep loss on an individual’s overall health.
Sleep loss can have an impact on many different aspects of an individual from brain function,
heart disease, immunological function, and can lead to metabolic impairments (Faraut et al.,
2012; Mullington et al., 2009; Ramlackhansingh et al., 2011). Some studies have shown that
increased inflammatory phenotypes are correlated with increased risks of cardiovascular diseases
(Ferrie et al, 2007; Meier-Ewert et al., 2001). In relation to cognitive function, studies have
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shown that sleep loss leads to increased retention of metabolic waste, which can enhance
inflammatory responses that may lead to chronic disease states (Xie et al., 2013). Along with
some findings that support previous research on the impacts of sleep fragmentation or sleep loss
on inflammatory responses, the role of glucocorticoids in mediating pro-inflammatory cytokines
such as IL-1β or TNF-α is better understood from this study. Sleep fragmentation has been
shown to activate the HPA axis which leads to the increase of glucocorticoids in circulation to
aid in regulating stress responses (Meerlo et al., 2008). Many of the effects of corticosterone
reinforced previous research that showed normal production of glucocorticoids enhance proinflammatory phenotypes, while high concentrations decreased these responses (Dhabhar, 2002;
Dhabhar and McEwen, 1999). Pro-inflammatory responses of the brain varied by region and
cytokine, thus there is mixed support that glucocorticoids increased the inflammatory phenotypes
when mice were subjected to sleep loss (Lannan et al., 2012; Munhoz et al., 2006). In some brain
regions (PFC) and peripheral tissues (liver, spleen, adipose tissue), ADX + CORT mice
displayed reduced TNF-α levels (Table 3). Other tissues also had reduced IL-1β expression
levels (Table 2), which was seen in hypothalamus, liver, spleen, and adipose tissue. Given the
contrary evidence, further research needs to be conducted to fully understand the mechanisms in
which glucocorticoids may be mediating these inflammatory responses. Other potential factors
that may be affecting these inflammatory responses could be epinephrine and norepinephrine
levels and given the different conditions in which some mice have removed adrenals, they are
also at loss of production of these catecholamines. Future studies should aim to control for the
loss of these important hormones. Many of the corticosterone effects also seemed to have sex
differences as well but was dependent upon tissue type. The findings from this study are
supported by previous research that shows females have an increased pro-inflammatory response
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compared to males (Irwin, Carrillo, and Olmstead, 2010). The findings from this research can be
used to potentially develop treatments for patients that suffer from sleep loss, as seen with OSA,
sleep disorders, or even shift workers. The effects of sleep loss on human health are not well
understood, so further research on how to assess the effects of sleep loss, how to better treat
sleep loss, and to distinguish the sex differences of sleep loss are needed. This study sheds light
on some of the impacts of sleep loss on overall health, but future studies need to improve
controlling for variation in the different factors assessed in this study.
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Figure 1. Experimental Protocol for Surgery and ASF
Experimental protocol for surgery, recovery, and sleep fragmentation experiment. Before sleep
fragmentation (SF) was conducted, half of the mice were subjected to bilateral adrenalectomy
(ADX), in which both adrenal glands were removed from mice. The other half were subjected to
a sham-adrenalectomy (Sham), in which the adrenal glands were left intact. All mice were
provided fluids and pain medication as needed. After surgery, all mice were allowed to recover
for 1 week prior to acclimation and SF. After 1 week of recovery, mice were allowed to
acclimate to the SF chambers for four days (days 1-4). Proceeding acclimation, the acute sleep
fragmentation groups (SF) mice were subjected to SF in an automated SF chamber for 24 hours
(day 5). A horizontal bar sweeps across the cage floor every 2 minutes (120 sec) to ensure sleep
loss occurred at a regular interval. The control (CON) groups for SF were housed in the same SF
chambers, except the bar remained motionless (day 5). After 24 hours of ASF or CON treatment,
mice (SF: n = 10/group; CON: n = 10/group) were rapidly decapitated for trunk blood collection
and peripheral tissue collection to assess gene expression levels. All mice were 8-12 weeks of
age, were subjected to 12 hours light: 12 hours dark cycles with lights turned on at 0800 and
lights turned off at 2000 with food and water provided ad libitum.
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